A standard lipid panel measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides, providing a picture of cardiovascular risk factors
The mechanisms, the evidence, the side effects (yes, we need to talk about those), and what happens when people stop taking them
The report describes prescribing volumes and patient characteristics over time, by medication, and by FDA-labeled use (e.g., ADM, AOM, or unknown)
[Toxicologic significance of the interaction of foreign substances with glutathione and glutathione S-transferases]
A synthesis of preclinical and population-level evidence now indicates that these agents may influence the development and progression of several OACs, particularly hepatocellular carcinoma (HCC), pancreatic cancer, and colorectal cancer (CRC)